Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 42 | 572.9 | 193 | 566.5 | 23 | 363.9 | 100 | 320.2 |
| Esophagus | * | # | 3 | # | * | # | 3 | # |
| Stomach | * | # | 3 | # | * | # | 1 | # |
| Colon excluding Rectum | 6 | 100.2** | 20 | 59.0 | * | # | 9 | 29.1** |
| Rectum and Rectosigmoid Junction | * | # | 9 | 27.0** | * | # | 2 | # |
| Liver | * | # | 2 | # | * | # | 1 | # |
| Pancreas | * | # | 3 | # | * | # | 5 | 20.0** |
| Lung and Bronchus | 8 | 110.6** | 44 | 134.1 | 9 | 141.1** | 43 | 131.6 |
| Melanoma of the Skin | * | # | 3 | # | * | # | 1 | # |
| Prostate | * | # | 47 | 139.4 | * | # | 4 | # |
| Urinary Bladder | * | # | 7 | 17.8** | * | # | 4 | # |
| Kidney and Renal Pelvis | * | # | 7 | 18.5** | * | # | 4 | # |
| Brain and Other Nervous System | * | # | 4 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 7 | 18.4** | * | # | 2 | # |
| Myeloma | * | # | 1 | # | * | # | 0 | # |
| Leukemia | * | # | 7 | 20.2** | * | # | 4 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 31 | 386.5 | 165 | 406.8 | 21 | 250.1 | 80 | 187.1 |
| Colon excluding Rectum | * | # | 11 | 24.2** | * | # | 8 | 15.6** |
| Rectum and Rectosigmoid Junction | * | # | 9 | 20.7** | * | # | 2 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 2 | # | * | # | 8 | 19.0** |
| Lung and Bronchus | 5 | 60.3** | 29 | 70.3 | * | # | 21 | 50.3 |
| Melanoma of the Skin | * | # | 1 | # | * | # | 0 | # |
| Breast | 8 | 100.1** | 39 | 97.7 | * | # | 2 | # |
| Cervix Uteri | * | # | 3 | # | * | # | 0 | # |
| Corpus Uteri | * | # | 10 | 23.9** | * | # | 1 | # |
| Ovary | * | # | 12 | 31.0** | * | # | 9 | 21.9** |
| Urinary Bladder | * | # | 8 | 18.7** | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 5 | 12.7** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 10 | 24.9** | * | # | 6 | 16.3** |
| Myeloma | * | # | 3 | # | * | # | 2 | # |
| Leukemia | * | # | 4 | # | * | # | 3 | # |
Rates are per 100,000; Age-adjusted, 2000 US Std Million Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2005
Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
